Nathan J. Dowden - President & COO at Entrada Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President & COO
Issuer Symbol
TRDA on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Nathan J. Dowden since 10 Mar 2025

Holdings reported by Nathan J. Dowden for Entrada Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 213,598 $2,511,143 $11.76 03 Mar 2026 Direct
Stock Option (Right to Buy) 83,200 01 Mar 2026 Direct Common Stock

Transactions reported by Nathan J. Dowden for Entrada Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.